U.S. FDA Accepts Viatris New Drug Application for Fast-Acting Meloxicam for the Treatment of Moderate-to-Severe Acute Pain

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. SPCX
2. ABBV
3. META
4. MU
5. SPY
6. ACN
7. NVDA
8. IBM
9. PFE
10. TSLA

Go back to U.S. FDA Accepts Viatris New Drug Application for Fast-Acting Meloxicam for the Treatment of Moderate-to-Severe Acute Pain
(NASDAQ: VTRS) Delayed: 15.77 +0.39 (2.54%)
Previous Close $15.38    52 Week High $ 
Open $15.32    52 Week Low $ 
Day High $15.80    P/E N/A 
Day Low $15.22    EPS $ 
Volume 2,900,357